• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 6/10/24: How Serious Are You About Patient Centricity? Mark Cuban Talks Drug Pricing & more


The latest news for pharma industry insiders.

How Serious Are You About Patient Centricity?

Companies need to alter their thinking to better prioritize patients. Here are three simple yet impactful engagement elements that could help.

24% of Type 1 Diabetes Patients have Eating Disorders

Eating disorders among patients with type 1 diabetes have increased, which increases the risk for serious complications. Patients who skip insulin doses are at a three times greater risk of premature death.

Mark Cuban Talks Drug Pricing

Now more than two years into launching his alternative and transparent drug payment model, the longtime entrepreneur, in an interview with Pharm Exec, discusses the prescription drug cost landscape and shares his recipe for true disruption to the pharma pricing machine.

Germany’s Merck Bets on AI Drug-Design Partnerships, Rules Out Acquisitions – Interview

The German company sees greater value in teaming up with independent AI companies, rather than in an outright acquisition of a company that specializes in the technology.

GE HealthCare Increases Access to Precision Care Tools

GE HealthCare once again joins the world’s top medical and academic institutions at the Society of Nuclear Medicine and Molecular Imaging annual meeting to discuss today’s healthcare landscape and announce new precision care tools to meet providers’ most pressing needs – namely the accessibility of technologies and solutions for the global practice of personalized medicine.

EVERSANA on LinkedIn:

nsightful perspective from Justin Chase, EVP at EVERSANA INTOUCH Media. In this Q&A from Pharmaceutical Executive, he shares how a TikTok ban could impact pharma marketing and the importance of diversifying digital strategies.https://lnkd.in/eSSMzzQY

#PharmaMarketing #TikTokBan

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs